Literature DB >> 24980771

Left ventricular or biventricular pacing? Single or multielectrode leads? An implanter's viewpoint.

Kamal K Sethi1, Kabir Sethi, Surendra K Chutani.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24980771     DOI： 10.1007/s10840-014-9918-7

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN： 1383-875X            Impact factor:   1.900


× No keyword cloud information.
  28 in total

1.  Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes.

Authors:  Faisal M Merchant; E Kevin Heist; David McCarty; Prabhat Kumar; Saumya Das; Dan Blendea; Patrick T Ellinor; Theofanie Mela; Michael H Picard; Jeremy N Ruskin; Jagmeet P Singh
Journal:  Heart Rhythm       Date:  2010-02-01       Impact factor: 6.343

2.  Elimination of phrenic nerve stimulation occurring during CRT: follow-up in patients implanted with a novel quadripolar pacing lead.

Authors:  Paresh A Mehta; Anoop K Shetty; Mark Squirrel; Julian Bostock; C Aldo Rinaldi
Journal:  J Interv Card Electrophysiol       Date:  2011-07-21       Impact factor: 1.900

3.  Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program.

Authors:  Angel R León; William T Abraham; Anne B Curtis; James P Daubert; Westby G Fisher; John Gurley; David L Hayes; Randy Lieberman; Susan Petersen-Stejskal; Kevin Wheelan
Journal:  J Am Coll Cardiol       Date:  2005-12-20       Impact factor: 24.094

4.  The hemodynamic effect of intrinsic conduction during left ventricular pacing as compared to biventricular pacing.

Authors:  Berry M van Gelder; Frank A Bracke; Albert Meijer; Nico H J Pijls
Journal:  J Am Coll Cardiol       Date:  2005-12-20       Impact factor: 24.094

5.  A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial.

Authors:  Giuseppe Boriani; Wolfgang Kranig; Erwan Donal; Leonardo Calo; Michela Casella; Nicolas Delarche; Ignacio Fernandez Lozano; Gerardo Ansalone; Mauro Biffi; Eric Boulogne; Christophe Leclercq
Journal:  Am Heart J       Date:  2010-06       Impact factor: 4.749

6.  Meta-analysis of randomized controlled trials evaluating left ventricular vs. biventricular pacing in heart failure: effect on all-cause mortality and hospitalizations.

Authors:  Giuseppe Boriani; Beatrice Gardini; Igor Diemberger; Maria Letizia Bacchi Reggiani; Mauro Biffi; Cristian Martignani; Matteo Ziacchi; Cinzia Valzania; Maurizio Gasparini; Luigi Padeletti; Angelo Branzi
Journal:  Eur J Heart Fail       Date:  2012-04-17       Impact factor: 15.534

7.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

8.  Midterm 'super-response' to cardiac resynchronization therapy by biventricular pacing with fusion: insights from electro-anatomical mapping.

Authors:  Radu Vatasescu; Antonio Berruezo; Lluis Mont; David Tamborero; Marta Sitges; Etel Silva; Jose María Tolosana; Bárbara Vidal; David Andreu; Josep Brugada
Journal:  Europace       Date:  2009-10-31       Impact factor: 5.214

9.  Acute changes in electromechanical parameters during different pacing configurations using a quadripolar left ventricular lead.

Authors:  Cinzia Valzania; Maria J Eriksson; Mauro Biffi; Giuseppe Boriani; Fredrik Gadler
Journal:  J Interv Card Electrophysiol       Date:  2013-07-03       Impact factor: 1.900

10.  Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety.

Authors:  D Gras; D Böcker; M Lunati; H J J Wellens; M Calvert; N Freemantle; R Gervais; L Kappenberger; L Tavazzi; E Erdmann; J G F Cleland; J-C Daubert
Journal:  Europace       Date:  2007-05-31       Impact factor: 5.214
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.